Dr. Saira Zafar Sheikh, MD

Dr. Sheikh practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Sheikh's NPI, 1194928713, was assigned on June 10, 2007. Dr. Sheikh graduated from King Edward Medical University in 2003. Dr. Sheikh's Arizona license number on file is 80662.

Dr. Sheikh's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Sheikh's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Sheikh to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheikh practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sheikh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sheikh is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Sheikh's licenses on file in 2 states: Arizona and North Carolina.

Dmand AI lists joint pain, lupus, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Sheikh treats.

CMS data shows 56 Medicare services from Dr. Sheikh across 2 procedure codes in 2024, for 35 Medicare patients. Medicare paid $2,367 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Dr. Sheikh in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have arthritis, and 71% have high blood pressure. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sheikh's median patient age at 67, with 76% women.

In 2024, Dr. Sheikh wrote 435 Medicare Part D claims for 63 patients. 86% of them were for generic drugs. CMS names the drug for 256 of them, across 10 drugs with 11 or more claims each, at $87,475 in total drug cost. In 2023, CMS named 375 claims across 14 drugs.

Dr. Sheikh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sheikh as offering telehealth.

Dmand AI links 34 papers to Dr. Sheikh, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Lupus Erythematosus, Systemic, Double-Blind Method and Minority Groups. Dr. Sheikh has published most often in ACR Open Rheumatol. Dr. Sheikh's most frequent co-authors are Allen P. Anandarajah, MD, Anca D. Askanase, MD and Benjamin Harris Kaffenberger, MD.

Dmand AI links Dr. Sheikh to 8 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lupus Erythematosus, Systemic, Connective Tissue Diseases and Coronaviridae Infections. University of North Carolina, Chapel Hill sponsors the most, 3.

CMS Open Payments shows 96 general payments to Dr. Sheikh from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 83% of the total. GlaxoSmithKline, LLC. paid the most, $60,386. It also lists 10 research payments totaling $1,912 from 2016 to 2018.

Dr. Sheikh graduated from King Edward Medical University in 2003. Dr. Sheikh is a member of AAAAI and ACR.

Dr. Sheikh is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.